The Vanguard Group, Inc. recently announced the acquisition of new stake in Ally Financial Inc (NYSE:ALLY). The institutional investor has increased its shareholding in the Financial company by 1.13% to 27.32 million shares with purchase of 0.31 million shares. This fresh investment now brings its stake to 9.06% valued currently at $953.95 million. In addition, Harris Associates LP raised its holdings by 0.13 million to 26.16 million shares. And BlackRock Fund Advisors has lifted its position by 96.26% or 11.03 million shares – to 22.49 million shares.
Currently, there are 302.46M common shares owned by the public and among those 298.47M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 63 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 35 of these insider trades were purchases, accounting for 1,052,329 shares. Insider sales of the common stock occurred on 28 occasions, with total insider shares sold totaling 100,835 shares.
The top 3 mutual fund holders in Ally Financial Inc are Oakmark Fund, Vanguard Total Stock Market ETF, and iShares Core S&P Mid Cap ETF. Oakmark Fund owns 13.36 million shares of the company’s stock, all valued at over $466.5 million. Vanguard Total Stock Market ETF bought 6744.0 shares to see its total holdings expand to 8.47 million shares valued at over $295.74 million and representing 2.81% of the shares outstanding. iShares Core S&P Mid Cap ETF bought 7460.0 shares to bring its total holdings to over 8.25 million shares at a value of $288.02 million. iShares Core S&P Mid Cap ETF now owns shares totaling to 2.73% of the shares outstanding.
However, the script later moved the day high at 36.72, up 2.11%. The company’s stock has a 5-day price change of 9.96% and 47.52% over the past three months. ALLY shares are trading 4.01% year to date (YTD), with the 12-month market performance up to 38.68% higher. It has a 12-month low price of $21.58 and touched a high of $35.88 over the same period. ALLY has an average intraday trading volume of 4.48 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.16%, 16.67%, and 30.07% respectively.
Institutional ownership of Ally Financial Inc (NYSE: ALLY) shares accounts for 89.38% of the company’s 302.46M shares outstanding. Mutual fund holders own 42.24%, while other institutional holders and individual stakeholders account for 47.52% and 1.33% respectively.
It has a market capitalization of $10.96B and a beta (3y monthly) value of 1.39. The stock’s trailing 12-month PE ratio is 12.16, while the earnings-per-share (ttm) stands at $2.99. The company has a debt-to-equity ratio at 1.52. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.58% over the week and 2.72% over the month.
Analysts forecast that Ally Financial Inc (ALLY) will achieve an EPS of $0.56 for the current quarter, $0.78 for the next quarter and $5.35 for 2025. The lowest estimate earnings-per-share for the quarter is $0.28 while analysts give the company a high EPS estimate of $0.74. Comparatively, EPS for the current quarter was $0.82 a year ago. Earnings per share for the fiscal year are expected to increase by 7.02%, and 67.21% over the next financial year. EPS should shrink at an annualized rate of -2.87% over the next five years, compared to 0.18% over the past 5-year period.
Looking at the support for the ALLY, a number of firms have released research notes about the stock. Deutsche Bank stated their Buy rating for the stock in a research note on January 10, 2024, with the firm’s price target at $47.
